Form 4 for XYL Xylem Inc.
Accepted 2023-03-15 00:00:00 ET · period of report 2023-03-13 · accession 0001562180-23-002811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-15 | 2023-03-13 | XYL | Decker Patrick | Pres, CEO, Dir | M - OptEx | $36.81 | +56.3K | 343.9K | +20% | +$2.07M |
| DM | 2023-03-15 | 2023-03-13 | XYL | Decker Patrick | Pres, CEO, Dir | S - Sale+OE | $98.19 | -56.3K | 311.7K | -15% | -$5.53M |
| D | 2023-03-15 | 2023-03-13 | XYL | Decker Patrick | Pres, CEO, Dir | M - OptEx | $36.81 | -56.3K | 0 | -100% | -$2.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-13 | M | A | 56,298 | $36.81 | 343,862 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-13 | S | D | 24,106 | $98.60 | 287,564 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023. (F3) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $98.26 to $99.049. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 3 | Common | Common Stock | 2023-03-13 | S | D | 32,192 | $97.88 | 311,670 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $97.26 to $98.259. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 4 | Derivative | Stock Options (Right to buy) | 2023-03-13 | M | D | 56,298 | $36.81 | 0 | D | $36.81 · — to 2024-02-25 | 56,298 Common Stock | (F4) The February 25, 2014 option grant vested one-third on February 25, 2015, February 25, 2016 and February 25, 2017. |